Orion Pharma Limited's latest marketcap:
As of 07/05/2025, Orion Pharma Limited's market capitalization has reached $59.25 M. According to our data, Orion Pharma Limited is the 28471th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 59.25 M |
| Revenue (ttm) | 50.26 M |
| Net Income (ttm) | -887,795.58 |
| Shares Out | 234 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/05/2024 |
| Earnings Date | 11/16/2025 |
Orion Pharma Limited's yearly market capitalization.
| Date | Market Cap(BDT) | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | 59.25 M | -17.68% | 28471 |
| 12/30/2024 | 8.87 B | -52.39% | 25345 |
| 12/28/2023 | 18.63 B | -3.75% | 19824 |
| 12/29/2022 | 19.35 B | -9.22% | 18431 |
| 12/30/2021 | 21.32 B | 66.54% | 17545 |
| 12/30/2020 | 12.8 B | 103.35% | 18287 |
| 12/30/2019 | 6.29 B | -26.9% | 19730 |
| 12/27/2018 | 8.61 B | -24.44% | 17124 |
| 12/28/2017 | 11.4 B | 15.68% | 16387 |
| 12/29/2016 | 9.85 B | 14.4% | 14944 |
Company Profile
About Orion Pharma Limited
Orion Pharma Limited is a leading pharmaceutical company in Bangladesh, specializing in the creation, discovery, development, manufacturing, and marketing of a wide range of pharmaceutical products.
Product Portfolio
The company offers diverse dosage forms, including:
- Tablets & Capsules
- Syrups & Suspensions
- Injections
- Dry Powder for Syrup/Suspension
Therapeutic Categories
Orion Pharma produces medicines across multiple therapeutic groups, such as:
- Anticancer
- Antibiotics
- Anti-diabetics
- Anxiolytics
- Diuretics
- Cardiovascular Drugs
Additional Offerings
Beyond pharmaceuticals, the company also provides:
- Vaccines
- Health-related consumer products
- Electricity generation and supply
Company Background
Originally incorporated in 1965 as Orion Laboratories Limited, the company rebranded to Orion Pharma Limited in October 2010. Headquartered in Dhaka, Bangladesh, Orion Pharma has established itself as a trusted name in the pharmaceutical industry.
Frequently Asked Questions
-
What is Orion Pharma Limited's (DSE-ORIONPHARM) current market cap?As of 07/05/2025, Orion Pharma Limited (including the parent company, if applicable) has an estimated market capitalization of $59.25 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Orion Pharma Limited (DSE-ORIONPHARM) rank globally by market cap?Orion Pharma Limited global market capitalization ranking is approximately 28471 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.